Claudia Espinosa, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Astellas
    Topic:
    Cresemba (antifungal)
    Date added:
    04/20/2026
    Date updated:
    04/20/2026
    Relationship end date:
    02/11/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Merck
    Topic:
    Pneumococcal vaccine
    Date added:
    04/20/2026
    Date updated:
    04/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Pfizer
    Topic:
    Pneumococcal vaccine
    Date added:
    04/20/2026
    Date updated:
    04/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Melinta
    Topic:
    Oritavacin
    Date added:
    04/20/2026
    Date updated:
    04/20/2026
    Relationship end date:
    10/25/2024
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Enanta
    Topic:
    Zelicapavir (RSV antiviral)
    Date added:
    04/20/2026
    Date updated:
    04/20/2026
    Relationship end date:
    08/22/2025
Return to The Future of Pediatric Practice – Annual Conference 2026